Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
LIPOSCIENCE INC (LPDX)
|
Add to portfolio |
|
|
|
| Price: |
$5.24
| | Metrics |
| OS: |
15.3
|
M
| |
-34
|
% ROE
|
| Market cap: |
$80.1
|
M
| |
-61
|
% ROIC
|
|
Net cash:
|
$24.1
|
M
| |
$1.58
|
per share
|
|
EV:
|
$56
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($9.2)
|
M
| |
|
|
|
EBIT
|
($11.2)
|
M
| |
|
|
| EPS |
($0.86)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| Revenues | 52.4 | 54.8 | 45.8 | 39.4 | 34.7 | 29.0 |
| Revenue growth | -4.4% | 19.6% | 16.4% | 13.4% | 19.9% | |
| Cost of goods sold | 10.7 | 10.1 | 8.5 | 8.1 | 7.8 | 7.4 |
| Gross profit | 41.6 | 44.7 | 37.3 | 31.2 | 26.9 | 21.6 |
| Gross margin | 79.5% | 81.6% | 81.4% | 79.3% | 77.6% | 74.6% |
| Sales and marketing | 27.7 | 22.4 | 21.3 | 15.2 | 13.0 | 12.1 |
| Research and development | | | | 7.3 | 6.2 | 7.2 |
| General and administrative | 11.9 | 10.4 | 8.6 | 7.3 | 7.0 | 6.0 |
| EBITA | -10.7 | 2.0 | -0.4 | 4.1 | 0.8 | -3.7 |
| EBITA margin | -20.3% | 3.6% | -0.8% | 10.4% | 2.2% | -12.9% |
| Amortization of intangibles | 0.0 | 0.0 | 0.0 | | | |
| EBIT | -10.7 | 1.9 | -0.4 | 4.1 | 0.8 | -3.7 |
| EBIT margin | -20.4% | 3.6% | -0.8% | 10.4% | 2.2% | -12.9% |
| Pre-tax income | 0.0 | 0.0 | 0.0 | 4.3 | 0.3 | -3.6 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | | | 0.8% | 0.0% |
| Net income | -12.5 | 0.2 | -1.2 | 4.3 | 0.3 | -3.6 |
| Net margin | -23.9% | 0.4% | -2.5% | 11.0% | 0.7% | -12.6% |
| |
| Diluted EPS | ($0.85) | $0.09 | ($0.69) | $617.00 | | |
| Shares outstanding (diluted) | 14.8 | 2.8 | 1.7 | 0.0 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|